-+ 0.00%
-+ 0.00%
-+ 0.00%

Anteris Announces Presentation of One-Year DurAVR Outcomes in 100 Patients at PCR Valves Conference

PUBT·11/16/2026 11:05:09
Diffusion vocale
Anteris Announces Presentation of One-Year DurAVR Outcomes in 100 Patients at PCR Valves Conference
  • Anteris Technologies will participate in PCR London Valves, held Nov. 22-24, 2026, in London.
  • Cleveland Clinic’s Rishi Puri will present one-year DurAVR transcatheter heart valve outcomes in a late-breaking session on Nov. 22.
  • The presentation covers clinical and hemodynamic outcomes in 100 patients with severe aortic stenosis who received the valve.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anteris Technologies Global Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160600PRIMZONEFULLFEED9878223) on November 16, 2026, and is solely responsible for the information contained therein.